[1]汪俊剑,黄少祥.化疗和放化疗同步治疗局部晚期非小细胞肺癌临床观察[J].国际放射医学核医学杂志,2008,32(5):317-319.
　WANG Jun-jian,HUANG Shao-xiang.Clinical observation of radiotherapy concurrently combined with chemotherapy for local advanced nonsmall cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):317-319.
点击复制

化疗和放化疗同步治疗局部晚期非小细胞肺癌临床观察(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第5期
页码:
317-319
栏目:
临床放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
Clinical observation of radiotherapy concurrently combined with chemotherapy for local advanced nonsmall cell lung cancer
作者:
汪俊剑;  黄少祥
300070 天津, 天津医科大学天津市第五中心医院呼吸科
Author(s):
WANG Jun-jian;  HUANG Shao-xiang
Department of Respiratory Medicine, Tianjin Medical University, the Fifth Central Hospital, Tianjin 300450, China
关键词:
癌; 非小细胞肺; 药物疗法; 联合; 放射疗法
Keywords:
Carcinoma; non-small cell lung; Drug therapy; combination; Radiotherapy
摘要:
目的 比较放化疗联合治疗与单纯化疗对局部晚期非小细胞肺癌(NSCLC)的临床疗效及安全性。方法 65例不能手术的NSCLC患者,分为单纯化疗组(A组)30例、放化疗联合组(B组)35例,A组给予紫杉醇联合顺铂方案化疗两周期,B组同A组并给予同步放疗方案。对比两组疗效及安全性。结果 A组治疗有效率、1年生存率分别为36.7%、30.0%,B组分别为65.7%、54.3%,B组较A组明显提高(χ2值分别为10.581和9.339,P<0.05)。患者治疗后主要不良反应为骨髓抑制及肝功能异常;A组白细胞减少、血小板减少和肝功能异常发生率分别为33.3%、3.3%和56.7%,B组则分别为36.6%、10.0%和60.0%,两组相比均无显著性差异(χ2值分别为2.011,0.007,2.206,P>0.05)。结论 局部晚期NSCLC放化疗联合治疗优于单纯化疗,不良反应能耐受。
Abstract:
Objective To compare the efficacy and adverse effects of radiotherapy currently combined with different chemotherapy for local advanced non-small cell lung cancer (NSCLC).Methods Sixty-five patients with NSCLC were divided into two groups.Group A was given taxot and cisplatin, and group B was given taxol and cisplatin combined with radiotherapy.The two groups were compared on the efficacy and safety.Results The total response (CR+PR) were 36.7% (group A), 65.7% (group B),A-a=10.581, P<0.05.The 1 year survival rates of group A were 30.0% and 54.3% of group B,χ2=9.339, P<0.05.The adverse effects showed no significant difference (χ2 value was 2.011, 0.007, 2.206 respectively, P>0.05).Conclusion The radiotherapy concurrently combined with taxol and cisplatin chemotherapy for patients with NSCLC could be more effectively, and the patients could tolerate the side effects, this therapy method was secure and receivable.

参考文献/References:

[1] Ginsberg RJ,Vokes EE,Rosenzweig K.Non-small-cell lung cancer.De Vita VT,Hellman S,Rosenberg SA.Cancer:principles and practice of oncology[M].6thed,Philadelphia:Lippincott Raven Co,2001:925-983.
[2] Socinski MA,Morris DE,Masters GA,et al.Chemotherapeutic management of stage IV non-small-cell lung cancer[J].Chest,2003,123(1 Suppl):226S-243S.
[3] 吴瑾,周莉华,蒋晓东.三维适形放疗联合GP方案同步治疗局部晚期非小细胞肺癌临床观察[J].临床肺科杂志,2007,12(10):1039-1040.
[4] 李全福,杨毅,丁祥,等.恶性肿瘤治疗中放化疗应用的时机和顺序[J].现代肿瘤医学,2005,13(6):851-853.4
[5] Fietkau R.Concomitant radiochemotherapy of advanced non-smallcel lung cancer[J].Lung Cancer,2001,33(Suppl 1):S65-S76.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
　Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
　Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[3]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
　Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[4]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[5]龙再颖,汤春静,于立明,等.甲状腺乳头状癌术后刺激状态Tg与颈部淋巴结转移关系的研究[J].国际放射医学核医学杂志,2013,37(1):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
　LONG Zai-ying,TANG Chun-jing,YU Li-ming,et al.The correlation between the stimulated thyroglobulin level after surgery in papillary thyroid carcinoma and cervical lymph node metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):27.[doi:10.3760/cma.j.issn.1673-4114.2013.01.008]
[6]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
　ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[7]任凌,戴皓洁.125Ⅰ粒子在头颈部腺样囊性癌综合治疗中的作用[J].国际放射医学核医学杂志,2011,35(1):13.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
　REN Ling,DAI Hao-jie.The effect of 125I seed in comprehensive therapy of the head and neck adenoid cystic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):13.[doi:10.3760/cma.j.issn.1673-4114.2011.01.004]
[8]李红兵,陈勇,曾建国,等.肝动脉化疗性栓塞结合Ⅱ期手术切除治疗巨块型外生型肝癌[J].国际放射医学核医学杂志,2010,34(1):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
　LI Hong-bing,CHEN Yong,ZENG Jian-guo,et al.Treatment of massive extrahepatic growing hepatocellular carcinoma with TACE in combination with secondary resection[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
[9]付晓昉,王秀梅,许建春.放射性榄香烯三羰基铼配合物在荷小细胞肺癌裸鼠体内的分布及其对肿瘤的生长抑制作用[J].国际放射医学核医学杂志,2009,33(6):335.[doi:10.3760/cma.j.issn.1673-4114.2009.06.004]
　FU Xiao-fang,WANG Xiu-mei,XU Jian-chun.Anti-tumor effect of elemene tricarbonyl rhenium-188 complex to small cell lung cancer and its biodistribution in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):335.[doi:10.3760/cma.j.issn.1673-4114.2009.06.004]
[10]郑磊,李前伟.18F-氟脱氧葡萄糖PET在原发陛肝细胞癌中的应用[J].国际放射医学核医学杂志,2008,32(1):23.
　ZHENG Lei,LI Qian-wei.Application of positron emission tomography with 18F-fluorodeoxyglucose in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):23.
[11]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
　Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[12]戈畅,梁硕.化疗联合DC-CIK生物治疗非小细胞肺癌的临床价值及CT灌注成像的疗效评价[J].国际放射医学核医学杂志,2014,38(6):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
　Ge Chang,Liang Shuo.The clinical value and CT perfusion evaluation in chemotherapy combined with DC-CIK biological treatment of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):377.[doi:10.3760/cma.j.issn.1673-4114.2014.06.007]
[13]黄少祥,樊体强.塞来昔布对非小细胞肺癌移植瘤的辐射增敏实验研究[J].国际放射医学核医学杂志,2013,37(3):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
　HUANG Shao-xiang,FAN Ti-qiang.Radiosensitization on non-small cell lung cancer induced by celecoxib[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):150.[doi:10.3760/cma.j.issn.1673-4114.2013.03.006]
[14]于丽娟,李迎辞,王文志,等.PET-CT及PET-CT结合Lung VCAR软件对非小细胞肺癌肺门区淋巴结的诊断分析[J].国际放射医学核医学杂志,2012,36(6):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
　YU Li-juan,LI Ying-ci,WANG Wen-zhi,et al.Value of PET-CT and PET-CT combined with Lung VCAR software in the diagnosis of hilar area lymph nodes of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):323.[doi:10.3760/cma.j.issn.1673-4114.2012.06.002]
[15]刘莉,杨景魁.125I粒子植入治疗非小细胞肺癌的护理及辐射防护[J].国际放射医学核医学杂志,2012,36(3):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
　LIU Li,YANG Jing-kui.Radiation protective nursing intervene of 125I seed implantation in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):172.[doi:10.3760/cma.j.issn.1673-4114.2012.03.013]
[16]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
　LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[17]吴红宇,贺晓东,刘宇,等.呼吸门控放疗非小细胞肺癌[J].国际放射医学核医学杂志,2011,35(5):314.[doi:10.3760/cma.j.issn.1673-4114.2011.05.015]
　WU Hong-yu,HE Xiao-dong,LIU Yu,et al.Respiratory gated radiotherapy for non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):314.[doi:10.3760/cma.j.issn.1673-4114.2011.05.015]
[18]陆光兵,刘丽.125I粒子联合EP方案治疗局部晚期非小细胞肺癌的临床分析[J].国际放射医学核医学杂志,2010,34(2):105.[doi:10.3760/cma.j.issn.1673-4114.2010.02.012]
[19]鲁胜男,冯彦林.18F-FDG PET-CT在评价肺癌化疗疗效中的应用[J].国际放射医学核医学杂志,2010,34(3):164.
　LU Sheng-nan,FENG Yan-lin.The application of 18F-FDG PET-CT in evaluation of the value of lung cancer chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):164.
[20]姚立新,付占昭,顾涛,等.99Tcm-甲氧基异丁基异腈SPECT评价非小细胞肺癌化疗疗效[J].国际放射医学核医学杂志,2009,33(5):272.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.005]
　YAO Li-xin,FU Zhan-zhao,GU Tao,et al.99Tcm-methoxyisobutylisonitrile SPECT imaging evaluate chemotherapy of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):272.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.005]

备注/Memo

备注/Memo:
收稿日期:2008-06-05。
通讯作者:汪俊剑(E-mail:wangjunjian_2002@126.com)
更新日期/Last Update: 1900-01-01